Fondazione IRCCS Istituto Nazionale dei Tumori (INT) is one of the main national and international referral centers for the treatment and study of cancer and it is the largest comprehensive cancer centre in Italy. Since its establishment (1928), it has aimed to provide the highest standards of cancer care and to pursue pre-clinical and clinical research in such a way as to swiftly translate innovation into better prevention, diagnosis, therapy and rehabilitation for Italian cancer patients.
Istituto Nazionale Tumori strongly pursues the objective of multidisciplinary care, working through disease-based multidisciplinary groups. This provides the most appropriate diagnostic and therapeutic options, based on state-of-the-art scientific evidence, within a framework of integrated knowledge, resource management, and research support.
Istituto Nazionale Tumori has a long-standing record on rare cancers, serving as one of the Italian reference centers for several rare cancers, including childhood cancers, sarcomas, head & neck cancers, peritoneal and pleural mesothelioma and thymoma, neuroendocrine tumors, male genital tumors, rare female genital cancers, rare digestive cancers, in addition to haematological cancers. It coordinates the Italian Rare Cancer Network, i.e., a healthcare national network exploiting telemedicine for distant rare adult solid cancer case-sharing between reference centers and medical oncology facilities throughout Italy. It is the coordinating Institution of the Joint Action on Rare Cancers of the European Union and serves as the domain leader for sarcomas and for head & neck rare cancers within the EU “EUropean reference network on Rare Adult CANcers” (EURACAN).
Tax
Please note that doctors taking part in a CTC in Italy will be subject to paying Italian tax
